Fallah P, Arefian E, Naderi M, Aghaee-Bakhtiari S, Atashi A, Ahmadi K
Mol Biol Rep. 2013; 40(8):4713-9.
PMID: 23673476
DOI: 10.1007/s11033-013-2567-6.
Scott L, Bryant A, Webster A, Farrant J
Clin Exp Immunol. 1994; 95(1):10-3.
PMID: 8287592
PMC: 1534626.
DOI: 10.1111/j.1365-2249.1994.tb06007.x.
Nadler L, Reinherz E, Schlossman S
Cancer Chemother Pharmacol. 1980; 4(1):11-5.
PMID: 6988098
DOI: 10.1007/BF00255452.
Bona C, Fauci A
J Clin Invest. 1980; 65(3):761-7.
PMID: 6986413
PMC: 371420.
DOI: 10.1172/JCI109724.
Thiel E, Lau B, Rodt H, Jager G, Pachmann K
Blut. 1981; 42(5):315-22.
PMID: 6972241
DOI: 10.1007/BF00996848.
Expansion of Fc receptor-bearing T lymphocytes in patients with immunoglobulin G and immunoglobulin A myeloma.
Hoover R, Hickman S, Gebel H, Rebbe N, Lynch R
J Clin Invest. 1981; 67(1):308-11.
PMID: 6969732
PMC: 371601.
DOI: 10.1172/JCI110028.
[Malignant T-cell lymphoma with osteomyelitis-like bone infiltration].
MITTELMEIER H, Schmitt O
Arch Orthop Trauma Surg (1978). 1980; 96(4):291-4.
PMID: 6967305
DOI: 10.1007/BF00432868.
Immunohistological analysis of Hodgkin's and Sternberg-reed cells: detection of a new antigen and evidence for selective IgG uptake in the absence of B cell, T cell and histiocytic markers.
STEIN H, Gerdes J, Kirchner H, Diehl V, Schaadt M, Bonk A
J Cancer Res Clin Oncol. 1981; 101(1):125-34.
PMID: 6792208
DOI: 10.1007/BF00405073.
Severe deficiency of B lymphocytes in peripheral blood from multiple myeloma patients.
Pilarski L, Mant M, Ruether B, Belch A
J Clin Invest. 1984; 74(4):1301-6.
PMID: 6332828
PMC: 425297.
DOI: 10.1172/JCI111540.
Selective IgA deficiency: analysis of Ig production in vitro.
Inoue T, Okubo H, Kudo J, Ikuta T, Hachimine K, Shibata R
J Clin Immunol. 1984; 4(3):235-41.
PMID: 6234324
DOI: 10.1007/BF00914971.
Immunological cell markers on lymphoblasts of patients with acute lymphatic leukemia.
Schwenk H
Z Kinderheilkd. 1974; 118(2):87-95.
PMID: 4613037
DOI: 10.1007/BF00440024.
Idiotypic specificity of surface immunoglobulin and the maturation of leukemic bone-marrow-derived lymphocytes.
Fu S, Winchester R, Feizi T, Walzer P, KUNKEL H
Proc Natl Acad Sci U S A. 1974; 71(11):4487-90.
PMID: 4612522
PMC: 433911.
DOI: 10.1073/pnas.71.11.4487.
Delay and not deficiency in cap formation of peripheral blood B cells in patients with multiple myeloma.
Zhang X, Klein B, Duperray C, BROCHIER J, Bataille R
J Clin Immunol. 1988; 8(4):244-9.
PMID: 3137244
DOI: 10.1007/BF00916552.
Cytochemistry of dipeptidylaminopeptidase IV and II in normal and neoplastic lymphoid cells.
Invernizzi R, Bertolino G, Girino M, Perseghin P, Michienzi M, Nano R
Blut. 1985; 50(5):277-85.
PMID: 2859898
DOI: 10.1007/BF00319753.
The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors.
Commes T, Klein B, Jourdan M, Clofent G, Houssiau F, Grenier J
J Clin Immunol. 1989; 9(1):65-73.
PMID: 2495299
DOI: 10.1007/BF00917129.
Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes.
Cohen H
J Clin Invest. 1975; 55(1):84-93.
PMID: 1088910
PMC: 301720.
DOI: 10.1172/JCI107921.
T and B lymphocytes in humans. A review.
Kersey J
Am J Pathol. 1975; 81(2):446-58.
PMID: 1081344
PMC: 2032224.
Membrane difference in peripheral blood lymphocytes from patients with chronic lymphocytic leukemia and Hodgkin's disease.
Mintz U, Sachs L
Proc Natl Acad Sci U S A. 1975; 72(6):2428-32.
PMID: 1056037
PMC: 432772.
DOI: 10.1073/pnas.72.6.2428.
Membrane-bound immunoglobulins on human leukemic cells. Evidence for humoral immune responses of patients to leukemia-associated antigens.
METZGAR R, Mohanakumar T, Miller D
J Clin Invest. 1975; 56(2):331-8.
PMID: 807598
PMC: 436591.
DOI: 10.1172/JCI108097.
Immunological characterization of lymphoproliferative disorders by membrane markers.
HUBER H, Michlmayr G, Huber C, Falkensammer M
Klin Wochenschr. 1976; 54(15):699-708.
PMID: 790006
DOI: 10.1007/BF01470461.
